Guggenheim Capital’s Agios Pharmaceuticals AGIO Stock Holding History

Guggenheim Capital’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$595K	Sell	17,904 -851	-5%	-$28.3K	﹤0.01%	1090
2025 Q1	$550K	Buy	18,755 +5,052	+37%	+$148K	0.01%	1153
2024 Q4	$450K	Buy	+13,703	New	+$450K	﹤0.01%	1304
2020 Q4	–	Sell	-49,530	Closed	-$1.73M	–	2037
2020 Q3	$1.73M	Sell	49,530 -5,610	-10%	-$196K	0.01%	948
2020 Q2	$2.95M	Buy	55,140 +6,308	+13%	+$337K	0.02%	715
2020 Q1	$1.73M	Sell	48,832 -9,580	-16%	-$340K	0.02%	845
2019 Q4	$2.79M	Buy	58,412 +5,610	+11%	+$268K	0.02%	907
2019 Q3	$1.71M	Buy	52,802 +5,322	+11%	+$172K	0.01%	1081
2019 Q2	$2.37M	Sell	47,480 -250	-0.5%	-$12.5K	0.02%	981
2019 Q1	$3.22M	Sell	47,730 -968	-2%	-$65.3K	0.03%	854
2018 Q4	$2.25M	Sell	48,698 -2,881	-6%	-$133K	0.02%	982
2018 Q3	$3.98M	Buy	51,579 +5,470	+12%	+$422K	0.03%	850
2018 Q2	$3.88M	Sell	46,109 -2,915	-6%	-$246K	0.03%	868
2018 Q1	$4.01M	Sell	49,024 -2,040	-4%	-$167K	0.01%	1146
2017 Q4	$2.92M	Sell	51,064 -10,612	-17%	-$607K	0.01%	1382
2017 Q3	$4.12M	Sell	61,676 -786	-1%	-$52.5K	0.01%	1179
2017 Q2	$3.21M	Buy	62,462 +7,270	+13%	+$374K	0.01%	1279
2017 Q1	$3.22M	Buy	55,192 +4,920	+10%	+$287K	0.01%	1294
2016 Q4	$2.1M	Sell	50,272 -29,384	-37%	-$1.23M	0.01%	1645
2016 Q3	$4.21M	Buy	79,656 +14,617	+22%	+$772K	0.01%	1113
2016 Q2	$2.73M	Sell	65,039 -4,075	-6%	-$171K	0.01%	1359
2016 Q1	$2.81M	Sell	69,114 -22,186	-24%	-$901K	0.01%	1337
2015 Q4	$5.93M	Sell	91,300 -13,205	-13%	-$857K	0.02%	942
2015 Q3	$7.38M	Sell	104,505 -3,463	-3%	-$244K	0.02%	875
2015 Q2	$12M	Buy	107,968 +15,399	+17%	+$1.71M	0.03%	767
2015 Q1	$8.73M	Buy	92,569 +20,922	+29%	+$1.97M	0.02%	910
2014 Q4	$8.03M	Sell	71,647 -2,355	-3%	-$264K	0.02%	923
2014 Q3	$4.54M	Buy	74,002 +727	+1%	+$44.6K	0.01%	1230
2014 Q2	$3.36M	Buy	+73,275	New	+$3.36M	0.01%	1398